Capture hydrolysis signals in the microsomal stability assay: Molecular mechanisms of the alkyl ester drug and prodrug metabolism

https://doi.org/10.1016/j.bmcl.2011.12.005Get rights and content

Abstract

The hydrolysis of carboxylic acid esters is often catalyzed by carboxylesterases in human liver microsomes, which is also a common ‘noise’ in the microsomal stability assay, a widely used screening protocol in drug discovery to monitor the activity of cytochrome P450 enzymes. Herein, we captured this ‘noise’, the hydrolysis signal of small alkyl ester drugs and prodrugs with a unique pairwise analysis of Pfizer’s microsomal clearance database. The hydrolysis mechanisms were further elucidated with density functional theory and molecular docking approaches. The results suggested that the electronic properties of ester moieties, tetrahedral intermediate formation energies, and specific drug–enzyme molecular interactions are key factors for the determination of the metabolic fate of the studied alkyl esters, but individually these factors failed to correlate with the observed rate of hydrolysis.

Section snippets

Acknowledgments

The author thanks Pfizer’s high-throughput ADME screening group for historical HLM data generation; and Dr. Chris Keefer for programing and implementing a pairwise analysis tool on Pfizer’s computing platform.

References and notes (22)

  • C.E. Keefer et al.

    Bioorg. Med. Chem.

    (2011)
  • H. Sun et al.

    Bioorg. Med. Chem. Lett.

    (2009)
  • R.P. Meyer et al.

    Biochem. Biophys. Res. Commun.

    (2001)
  • A. Parkinson et al.
  • Drug Approvals and Databases, U.S. Food and Drug Administration,...
  • J.L. Bolton et al.

    J. Chem. Res. Toxicol.

    (2000)
  • P.F. Hollenberg et al.

    Chem. Res. Toxicol.

    (2008)
  • Sun, H.; Keefer, C. E.; Scott, D. O. Drug Metabolism Letters 2011, 5, in...
  • S. Bencharit et al.

    Nat. Struct. Biol.

    (2003)
  • H. Sun et al.

    Chem. Biol. Drug Des.

    (2010)
  • Cited by (11)

    • Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597

      2012, Biochemical Pharmacology
      Citation Excerpt :

      Drugs and prodrugs that are esters of carboxylic acids are in general more lipophilic and better absorbed than the corresponding carboxylic acid [20], making them popular for clinical use. CES1 and CES2 are known to metabolize these ester drugs [20]. Thus, covalent interaction of pharmaceutical agents with CES1 and CES2 leading to enzyme inhibition may affect the metabolism and bioavailability of many ester drugs that are already in use.

    • Using Crystal Structures of Drug-Metabolizing Enzymes in Mechanism-Based Modeling for Drug Design

      2020, Structural Biology in Drug Discovery: Methods, Techniques, and Practices
    View all citing articles on Scopus
    View full text